Ratchaphruek Hospital PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,147	1,162	1,125	1,161	1,326	1,413
Revenue Growth (YoY)	0.98%	3.27%	-3.05%	-12.49%	-6.12%	76.72%
Cost of Revenue	772	771.53	751.44	750.58	827.01	746.98
Gross Profit	374.7	390.47	373.73	410.01	499.17	665.58
Selling, General & Admin	187.3	184.67	181.22	191.46	149.5	167.72
Other Operating Expenses	-21.1	-21.6	-17.85	-	-	-
Operating Expenses	166.21	163.07	163.36	191.46	149.5	167.72
Operating Income	208.49	227.41	210.37	218.55	349.67	497.86
Interest Expense	-0.47	-0.51	-0.57	-2.11	-5.55	-6.69
Interest & Investment Income	4.14	4.14	6.58	2.78	0.81	0.35
Other Non Operating Income (Expenses)	-	-	-	14.16	13.26	11.54
EBT Excluding Unusual Items	212.16	231.03	216.37	233.38	358.19	503.07
Pretax Income	212.16	231.03	216.37	233.38	358.19	503.07
Income Tax Expense	43.97	48.66	43.84	48.92	71.73	100.07
Net Income	168.19	182.37	172.53	184.45	286.47	402.99
Net Income to Common	168.19	182.37	172.53	184.45	286.47	402.99
Net Income Growth	-5.10%	5.70%	-6.46%	-35.61%	-28.92%	329.43%
Shares Outstanding (Basic)	529	533	546	546	546	546
Shares Outstanding (Diluted)	529	533	546	546	546	546
Shares Change (YoY)	-3.04%	-2.33%	-0.01%	-	-	-
EPS (Basic)	0.32	0.34	0.32	0.34	0.52	0.74
EPS (Diluted)	0.32	0.34	0.32	0.34	0.52	0.74
EPS Growth	-2.12%	8.22%	-6.46%	-35.61%	-28.92%	329.43%
Free Cash Flow	116.06	164.69	230.62	342.38	420.32	271.25
Free Cash Flow Per Share	0.22	0.31	0.42	0.63	0.77	0.50
Dividend Per Share	0.280	0.280	0.290	0.300	0.350	0.300
Dividend Growth	-3.45%	-3.45%	-3.33%	-14.29%	16.67%	130.77%
Gross Margin	32.68%	33.60%	33.22%	35.33%	37.64%	47.12%
Operating Margin	18.18%	19.57%	18.70%	18.83%	26.37%	35.24%
Profit Margin	14.67%	15.70%	15.33%	15.89%	21.60%	28.53%
Free Cash Flow Margin	10.12%	14.17%	20.50%	29.50%	31.69%	19.20%
EBITDA	283.31	302.14	284.77	303.46	440.29	584.49
EBITDA Margin	24.71%	26.00%	25.31%	26.15%	33.20%	41.38%
D&A For EBITDA	74.81	74.73	74.4	84.91	90.62	86.62
EBIT	208.49	227.41	210.37	218.55	349.67	497.86
EBIT Margin	18.18%	19.57%	18.70%	18.83%	26.37%	35.24%
Effective Tax Rate	20.72%	21.06%	20.26%	20.96%	20.02%	19.89%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.